🚚 FREE U.S. Shipping on Orders Over $500
SKU: HGH Frag 176-191 5MG

HGH Frag 176-191 (5mg)

HGH Fragment 176-191 is a synthetic 16-residue peptide corresponding to residues 176 through 191 of the human growth hormone sequence. It contains two cysteine residues at positions 7 and 14 of the fragment, which in the parent protein form a disulfide bridge.

This material is supplied as a characterized reference compound for non-clinical laboratory work, such as analytical method development for cysteine-containing peptides, disulfide mapping and redox-state determination, comparative studies against the parent hGH sequence and related fragment analogues, and in vitro assay development.

Compound Specifications

  • Sequence: Tyr-Leu-Arg-Ile-Val-Gln-Cys-Arg-Ser-Val-Glu-Gly-Ser-Cys-Gly-Phe
  • Sequence Length: 16 residues
  • Molecular Formula: C₇₈H₁₂₅N₂₃O₂₃S₂ (reduced, linear form)
  • Molecular Weight: ~1817.1 g/mol (reduced); ~1815.1 g/mol if the Cys7-Cys14 disulfide is formed
  • CAS Number: 66004-57-7
  • Physical Form: Lyophilized powder

 

Storage & Handling
Store lyophilized powder at −20 °C, protected from light. Avoid moisture and repeated freeze-thaw cycles. Handle in accordance with standard laboratory safety practices.

FOR RESEARCH USE ONLY. Not for human consumption. Not intended for human or veterinary use. For laboratory research and analytical purposes only.

$80.00

Choose Quantity

Description

HGH Fragment 176-191 is a synthetic 16-residue peptide corresponding to residues 176 through 191 of the human growth hormone sequence. It contains two cysteine residues at positions 7 and 14 of the fragment, which in the parent protein form a disulfide bridge.

This material is supplied as a characterized reference compound for non-clinical laboratory work, such as analytical method development for cysteine-containing peptides, disulfide mapping and redox-state determination, comparative studies against the parent hGH sequence and related fragment analogues, and in vitro assay development.

Compound Specifications

  • Sequence: Tyr-Leu-Arg-Ile-Val-Gln-Cys-Arg-Ser-Val-Glu-Gly-Ser-Cys-Gly-Phe
  • Sequence Length: 16 residues
  • Molecular Formula: C₇₈H₁₂₅N₂₃O₂₃S₂ (reduced, linear form)
  • Molecular Weight: ~1817.1 g/mol (reduced); ~1815.1 g/mol if the Cys7-Cys14 disulfide is formed
  • CAS Number: 66004-57-7
  • Physical Form: Lyophilized powder

 

Storage & Handling
Store lyophilized powder at −20 °C, protected from light. Avoid moisture and repeated freeze-thaw cycles. Handle in accordance with standard laboratory safety practices.

FOR RESEARCH USE ONLY. Not for human consumption. Not intended for human or veterinary use. For laboratory research and analytical purposes only.

Additional information

Weight 0.1 lbs
Dimensions 1 × 1 × 2 in

Disclaimer: For Research Purposes Only

This content is supplied exclusively for research and educational purposes. Nothing presented here should be interpreted as approval, promotion, or encouragement of any non-laboratory use, improper handling, or non-research application of peptides intended for scientific investigation. Any references to specific peptides, their properties, or findings associated with them are provided solely as informational research content. This information does not constitute legal advice, clinical guidance, or a recommendation for personal, therapeutic, or non-research use. These compounds are intended only for controlled scientific work conducted by qualified and authorized individuals. Before making any decision regarding the purchase, possession, handling, or use of research peptides, consultation with qualified research professionals or legal counsel is strongly advised. All information should be used responsibly, ethically, and only in connection with legitimate academic, scientific, or investigative purposes. This notice applies broadly to all peptide-related content provided here and may be updated as needed.

0